Herbal tea in the treatment of diabetes mellitus

Ryan, Edmond A.; Imes, Sharleen; Wallace, Clarissa; Jones, Sherman
October 2000
Clinical & Investigative Medicine;Oct2000, Vol. 23 Issue 5, p311
Academic Journal
Objective: To evaluate the effects of a native herbal tea in patients with type 2 diabetes. Design: Randomized, placebo-controlled, single-blind study. Setting: The Metabolic Centre at the University of Alberta Hospitals. Subjects: Forty volunteers with type 2 diabetes. Interventions: After a 1 month "run-in" period, subjects drank 250 mL/d of either the herbal tea or a placebo tea for 10 days, and were followed up for a further 4 weeks. Outcome measures: A responder analysis defined as a 10% change in mean blood glucose levels based on 4 capillary glucose readings daily. Secondary end points included changes in HbA[sub 1c], fructosamine and response to a meal challenge using Ensure. Results: The responder analysis showed no benefit from the herbal tea. Fructosamine levels before and after tea therapy decreased significantly in both study groups. Mean HbA1c levels and incremental areas under the glucose curve (AUC) in the meal challenge did not change in either study group. These data were reanalysed in hyperglycemic subjects with HbA1c levels greater than 120% of normal. The responder analysis and HbA1c levels did not change in either group. Mean (and standard deviation) fructosamine levels, before and after tea therapy, were significantly lower in the herbal tea group than in the placebo tea group (361 [98] versus 338 [100] micro mol/L, p < 0.01 compared with 338 [60] versus 323 [49] micro mol/L, p = 0.08). In the hyperglycemic subgroup the mean AUC during the meal challenge, before versus after tea therapy, was 776 (369) versus 639 (331) mmol/L (p = 0.22) in the herbal tea group and 433 (125) versus 420 (173) mmol/L (p = 0.90) in the placebo group. Conclusions: Although the responder analysis failed to show an effect of the herbal tea, the data suggest there may be a short-term benefit from the tea in subjects with poor glycemic control.


Related Articles

  • Identifying Gender-Preferred Communication Styles within Online Cancer Communities: A Retrospective, Longitudinal Analysis. Durant, Kathleen T.; McCray, Alexa T.; Safran, Charles // PLoS ONE;Nov2012, Vol. 7 Issue 11, Special section p1 

    Background: The goal of this research is to determine if different gender-preferred social styles can be observed within the user interactions at an online cancer community. To achieve this goal, we identify and measure variables that pertain to each gender-specific social style. Methods and...

  • Comparison of high fibre diets, basal insulin supplements, and flexible insulin treatment for non-insulin dependent (type II) diabetics poorly controlled with sulphonylureas. Scott, A.R.; Attenborough, Y.; Peacock, I.; Fletcher, E.; Jeffcoate, W.J.; Tattersall, R.B. // BMJ: British Medical Journal (International Edition);9/17/88, Vol. 297 Issue 6650, p707 

    Explores the efficacy of managements for non-insulin-dependent diabetes. Administration of high fiber diet, basal insulin supplements and a regimen of insulin for diabetics; Absence of changes in hemoglobin A[sub 1] concentration during high fiber diet; Improvement of control of diabetes by...

  • Pathogenesis of Type 2 Diabetes: Implications for Metformin. DeFronzo, R.A. // Drugs;Dec1999 Supplement 1, Vol. 58 Issue 6, p29 

    Discusses the implications of the pathogenesis of type 2 diabetes for metformin. Insulin resistance in type 2 diabetes mellitus individuals; Defects in insulin action; Information on the initial therapeutic approach in type 2 diabetes mellitus patients.

  • The Antihyperglycaemic Effect of Metformin: Therapeutic and Cellular Mechanisms. Wiernsperger, N.F.; Bailey, C.J. // Drugs;Dec1999 Supplement 1, Vol. 58 Issue 6, p31 

    Metformin is regarded as an antihyperglycaemic agent because it lowers blood glucose concentrations in type 2 (non-insulin-dependent) diabetes without causing overt hypoglycaemia. Its clinical efficacy requires the presence of insulin and involves several therapeutic effects. Of these effects,...

  • Bariatric surgery for obese diabetic subjects.  // Internal Medicine Alert;6/30/2009 Clinical Briefs, p14 

    The article offers findings from a controlled trial in Australia which suggest that surgical therapy can be used as a cost-effective intervention for obesity in type 2 diabetes.

  • Combination Therapy for Type 2 Diabetes. Bell, David S. H. // American Family Physician;12/1/2001, Vol. 64 Issue 11, p1812 

    Editorial. Comments on the combination therapy for type 2 diabetes. Effectiveness of sulfonylurea as treatment for type 2 diabetes; Examination of the insulin therapy; Information on the combined insulin and oral therapy.

  • VTT searches for novel biomarkers and targets for preventing or treating Type 2 diabetes.  // Biomedical Market Newsletter;3/21/2012, Vol. 21, p1 

    The article offers information on two projects which aims at identifying new therapeutics and strategies for preventing Type 2 diabetes.

  • Acarbose noninferior to metformin in type 2 diabetes.  // Endocrine Today;Nov2013, Vol. 11 Issue 11, p9 

    The article discusses a research study published in an issue of the journal "The Lancet" which found that patients with type 2 diabetes treated with acarbose experienced similar improvements in HbAlc as those treated with metformin.

  • On "Exercise assessment and prescription in patients with type 2 diabetes...". Gentzel, Joseph B.; Hansen, Dominique; Peeters, Stefaan; Schotte, Michel // Physical Therapy;Aug2013, Vol. 93 Issue 8, p1141 

    A letter to the editor is presented in response to the article "Exercise Assessment and Prescription in Patients With Type 2 Diabetes in the Private and Home Care Setting: Clinical Recommendations From AXXON (Belgian Physical Therapy Association)" by D. Hansen et al. in the May 2013 issue, along...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics